SuperSonic Imagine : Strong Growth in the Group’s Revenue for the First 9 Months of the Year: +29% to Reach €13.6 Million

Regulatory News:

SuperSonic Imagine (Paris:SSI) (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialized in ultrasound medical imaging, today announces its revenue for the 3^rd quarter to September 30, 2014.

Unaudited data

Supersonic Imagine’s revenue for the first 9 months of 2014 totaled €13.6m, up +29% compared to the first 9 months of 2013. This figure includes other revenue, essentially derived from technology access fees, which is not part of the Group’s core business and will not occur regularly.

Over the first 9 months of 2014, the Group’s sales increased from €10,5m to €12.5m, a growth of 19%, primarily driven by Asia and the Americas. At constant currency exchange rates, growth was +20% year on year. Product sales and Services sales totaled €11.3m and €1.2m respectively, or 90% and 10% of sales over the period.

In the 3^rd quarter of 2014, SuperSonic Imagine recorded sales of €4.4m, up +22% compared to the 3^rd quarter of 2013. Sales of Services totaled €505k for the quarter (+30%), compared to €389k a year earlier. For the quarter, Services continued to represent a stable share of total sales (11%).

Jacques Souquet, SuperSonic Imagine’s Founder and Chairman of the Board, concludes: "The solid quarter we have just recorded reflects the continued commercial adoption of the Aixplorer platform in all the markets targeted by our company, and in particular the Americas zone where we have recorded an excellent 3^rd quarter performance. Hospitals are now convinced of the added value provided by our products, which make it possible to better detect and characterize a substantial number of pathologies in several clinical applications, notably regarding the breast, thyroid, liver and prostate.”

About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer^®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer^® is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™ Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer^® on the main markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to www.supersonicimagine.com